-
1
-
-
0026706261
-
Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily. Sequence identity with the Fas antigen
-
Oehm A, Behrmann I, Falk W, et al. Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily. Sequence identity with the Fas antigen. J Biol Chem 1992;267:10709-15.
-
(1992)
J Biol Chem
, vol.267
, pp. 10709-10715
-
-
Oehm, A.1
Behrmann, I.2
Falk, W.3
-
2
-
-
0033613143
-
Caspase activation: The induced-proximity model
-
Salvesen GS, Dixit VM. Caspase activation: the induced-proximity model. Proc Natl Acad Sci U S A 1999;96:10964-7.
-
(1999)
Proc Natl Acad Sci U S A
, vol.96
, pp. 10964-10967
-
-
Salvesen, G.S.1
Dixit, V.M.2
-
4
-
-
0031743648
-
p53 activates the CD95 (APO-1/Fas) gene in response to DNA damage by anticancer drugs
-
Muller M, Wilder S, Bannasch D, et al. p53 activates the CD95 (APO-1/Fas) gene in response to DNA damage by anticancer drugs. J Exp Med 1998;188:2033-45.
-
(1998)
J Exp Med
, vol.188
, pp. 2033-2045
-
-
Muller, M.1
Wilder, S.2
Bannasch, D.3
-
5
-
-
0034955033
-
New chemotherapy approaches in colorectal cancer
-
Grothey A, Schmoll HJ. New chemotherapy approaches in colorectal cancer. Curr Opin Oncol 2001;13:275-86.
-
(2001)
Curr Opin Oncol
, vol.13
, pp. 275-286
-
-
Grothey, A.1
Schmoll, H.J.2
-
6
-
-
0027509209
-
Prognostic value of p53 overexpression and c-Ki-ras gene mutations in colorectal cancer
-
Bell SM, Scott N, Cross D, et al. Prognostic value of p53 overexpression and c-Ki-ras gene mutations in colorectal cancer. Gastroenterology 1993;104:57-64.
-
(1993)
Gastroenterology
, vol.104
, pp. 57-64
-
-
Bell, S.M.1
Scott, N.2
Cross, D.3
-
7
-
-
0026496488
-
Expression of p53 protein in colorectal cancer and its relationship to short-term prognosis
-
Yamaguchi A, Kurosaka Y, Fushida S, et al. Expression of p53 protein in colorectal cancer and its relationship to short-term prognosis. Cancer 1992;70:2778-84.
-
(1992)
Cancer
, vol.70
, pp. 2778-2784
-
-
Yamaguchi, A.1
Kurosaka, Y.2
Fushida, S.3
-
8
-
-
2542496862
-
The roles of thymidylate synthase and p53 in regulating Fas-mediated apoptosis in response to antimetabolites
-
Longley DB, Allen WL, McDermott U, et al. The roles of thymidylate synthase and p53 in regulating Fas-mediated apoptosis in response to antimetabolites. Clin Cancer Res 2004;10:3562-71.
-
(2004)
Clin Cancer Res
, vol.10
, pp. 3562-3571
-
-
Longley, D.B.1
Allen, W.L.2
McDermott, U.3
-
9
-
-
20244383713
-
Time-dependency of the prognostic effect of carcinoembryonic antigen and p53 protein in colorectal adenocarcinoma
-
Diez M, Pollan M, Muguerza JM, et al. Time-dependency of the prognostic effect of carcinoembryonic antigen and p53 protein in colorectal adenocarcinoma. Cancer 2000;88:35-41.
-
(2000)
Cancer
, vol.88
, pp. 35-41
-
-
Diez, M.1
Pollan, M.2
Muguerza, J.M.3
-
10
-
-
2442659386
-
Prognostic value of proliferation, apoptosis, defective DNA mismatch repair, and p53 overexpression in patients with resected Dukes' B2 or C colon cancer: A North Central Cancer Treatment Group Study
-
Garrity MM, Burgart LJ, Mahoney MR, et al. Prognostic value of proliferation, apoptosis, defective DNA mismatch repair, and p53 overexpression in patients with resected Dukes' B2 or C colon cancer: a North Central Cancer Treatment Group Study. J Clin Oncol 2004;22:1572-82.
-
(2004)
J Clin Oncol
, vol.22
, pp. 1572-1582
-
-
Garrity, M.M.1
Burgart, L.J.2
Mahoney, M.R.3
-
11
-
-
0035980014
-
Mechanisms of differential activation of target gene promoters by p53 hinge domain mutants with impaired apoptotic function
-
Kong XT, Gao H, Stanbridge EJ. Mechanisms of differential activation of target gene promoters by p53 hinge domain mutants with impaired apoptotic function. J Biol Chem 2001;276:32990-3000.
-
(2001)
J Biol Chem
, vol.276
, pp. 32990-33000
-
-
Kong, X.T.1
Gao, H.2
Stanbridge, E.J.3
-
12
-
-
0037567586
-
Cooperation of two mutant p53 alleles contributes to Fas resistance of prostate carcinoma cells
-
Gurova KV, Rokhlin OW, Budanov AV, et al. Cooperation of two mutant p53 alleles contributes to Fas resistance of prostate carcinoma cells. Cancer Res 2003;63:2905-12.
-
(2003)
Cancer Res
, vol.63
, pp. 2905-2912
-
-
Gurova, K.V.1
Rokhlin, O.W.2
Budanov, A.V.3
-
13
-
-
0037165631
-
A mutant p53 can activate apoptosis through a mechanism distinct from those induced by wild type P53
-
He M, Rennie PS, Dragowska V, Nelson CC, Jia W. A mutant p53 can activate apoptosis through a mechanism distinct from those induced by wild type P53. FEBS Lett 2002;517:151-4.
-
(2002)
FEBS Lett
, vol.517
, pp. 151-154
-
-
He, M.1
Rennie, P.S.2
Dragowska, V.3
Nelson, C.C.4
Jia, W.5
-
14
-
-
0037063173
-
Novel gain of function activity of p53 mutants: Activation of the dUTPase gene expression leading to resistance to 5-fluorouracil
-
Pugacheva EN, Ivanov AV, Kravchenko JE, Kopnin BP, Levine AJ, Chumakov PM. Novel gain of function activity of p53 mutants: activation of the dUTPase gene expression leading to resistance to 5-fluorouracil. Oncogene 2002;21:4595-600.
-
(2002)
Oncogene
, vol.21
, pp. 4595-4600
-
-
Pugacheva, E.N.1
Ivanov, A.V.2
Kravchenko, J.E.3
Kopnin, B.P.4
Levine, A.J.5
Chumakov, P.M.6
-
15
-
-
0029027667
-
Effects of p53 mutants on wild-type p53-mediated transactivation are cell type dependent
-
Forrester K, Lupold SE, Ott VL, et al. Effects of p53 mutants on wild-type p53-mediated transactivation are cell type dependent. Oncogene 1995;10:2103-11.
-
(1995)
Oncogene
, vol.10
, pp. 2103-2111
-
-
Forrester, K.1
Lupold, S.E.2
Ott, V.L.3
-
16
-
-
0032125574
-
IFN-γ induces cell growth inhibition by Fas-mediated apoptosis: Requirement of STAT1 protein for up-regulation of Fas and FasL expression
-
Xu X, Fu XY, Plate J, Chong AS. IFN-γ induces cell growth inhibition by Fas-mediated apoptosis: requirement of STAT1 protein for up-regulation of Fas and FasL expression. Cancer Res 1998;58:2832-7.
-
(1998)
Cancer Res
, vol.58
, pp. 2832-2837
-
-
Xu, X.1
Fu, X.Y.2
Plate, J.3
Chong, A.S.4
-
17
-
-
0035958846
-
Induction of apoptosis and Fas receptor/Fas ligand expression by ischemia/reperfusion in cardiac myocytes requires serine 727 of the STAT-1 transcription factor but not tyrosine 701
-
Stephanou A, Scarabelli TM, Brar BK, et al. Induction of apoptosis and Fas receptor/Fas ligand expression by ischemia/reperfusion in cardiac myocytes requires serine 727 of the STAT-1 transcription factor but not tyrosine 701. J Biol Chem 2001;276:28340-7.
-
(2001)
J Biol Chem
, vol.276
, pp. 28340-28347
-
-
Stephanou, A.1
Scarabelli, T.M.2
Brar, B.K.3
-
18
-
-
0034254726
-
How Stat1 mediates constitutive gene expression: A complex of unphosphorylated Stat1 and IRF1 supports transcription of the LMP2 gene
-
Chatterjee-Kishore M, Wright KL, Ting JP, Stark GR. How Stat1 mediates constitutive gene expression: a complex of unphosphorylated Stat1 and IRF1 supports transcription of the LMP2 gene. EMBO J 2000;19:4111-22.
-
(2000)
EMBO J
, vol.19
, pp. 4111-4122
-
-
Chatterjee-Kishore, M.1
Wright, K.L.2
Ting, J.P.3
Stark, G.R.4
-
19
-
-
1242316989
-
STAT-1 interacts with p53 to enhance DNA damage-induced apoptosis
-
Townsend PA, Scarabelli TM, Davidson SM, Knight RA, Latchman DS, Stephanou A. STAT-1 interacts with p53 to enhance DNA damage-induced apoptosis. J Biol Chem 2004;279:5811-20.
-
(2004)
J Biol Chem
, vol.279
, pp. 5811-5820
-
-
Townsend, P.A.1
Scarabelli, T.M.2
Davidson, S.M.3
Knight, R.A.4
Latchman, D.S.5
Stephanou, A.6
-
20
-
-
0023945379
-
In vitro pharmacodynamics of 1-β-D-arabinofuranosylcytosine: Synergy of antitumor activity with cis-diamminedichloroplatinum(II)
-
Kern DH, Morgan CR, Hildebrand-Zanki SU. In vitro pharmacodynamics of 1-β-D-arabinofuranosylcytosine: synergy of antitumor activity with cis-diamminedichloroplatinum(II). Cancer Res 1988;48:117-21.
-
(1988)
Cancer Res
, vol.48
, pp. 117-121
-
-
Kern, D.H.1
Morgan, C.R.2
Hildebrand-Zanki, S.U.3
-
21
-
-
0031905299
-
In vitro and in vivo interaction between cisplatin and topotecan in ovarian carcinoma systems
-
Romanelli S, Perego P, Pratesi G, Carenini N, Tortoreto M, Zunino F. In vitro and in vivo interaction between cisplatin and topotecan in ovarian carcinoma systems. Cancer Chemother Pharmacol 1998;41:385-90.
-
(1998)
Cancer Chemother Pharmacol
, vol.41
, pp. 385-390
-
-
Romanelli, S.1
Perego, P.2
Pratesi, G.3
Carenini, N.4
Tortoreto, M.5
Zunino, F.6
-
22
-
-
0021118703
-
Quantitative analysis of dose-effect relationships: The combined effects of multiple drugs or enzyme inhibitors
-
Chou TC, Talalay P. Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul 1984;22:27-55.
-
(1984)
Adv Enzyme Regul
, vol.22
, pp. 27-55
-
-
Chou, T.C.1
Talalay, P.2
-
23
-
-
0023873482
-
Effects of vincristine in combination with methotrexate and other antitumor agents in human acute lymphoblastic leukemia cells in culture
-
Kano Y, Ohnuma T, Okano T, Holland JF. Effects of vincristine in combination with methotrexate and other antitumor agents in human acute lymphoblastic leukemia cells in culture. Cancer Res 1988;48:351-6.
-
(1988)
Cancer Res
, vol.48
, pp. 351-356
-
-
Kano, Y.1
Ohnuma, T.2
Okano, T.3
Holland, J.F.4
-
24
-
-
0034635373
-
Human and mouse Fas (APO-1/CD95) death receptor genes each contain a p53-responsive element that is activated by p53 mutants unable to induce apoptosis
-
Munsch D, Watanabe-Fukunaga R, Bourdon JC, et al. Human and mouse Fas (APO-1/CD95) death receptor genes each contain a p53-responsive element that is activated by p53 mutants unable to induce apoptosis. J Biol Chem 2000;275:3867-72.
-
(2000)
J Biol Chem
, vol.275
, pp. 3867-3872
-
-
Munsch, D.1
Watanabe-Fukunaga, R.2
Bourdon, J.C.3
-
25
-
-
0025916387
-
The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis
-
Itoh N, Yonehara S, Ishii A, et al. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 1991;66:233-43.
-
(1991)
Cell
, vol.66
, pp. 233-243
-
-
Itoh, N.1
Yonehara, S.2
Ishii, A.3
-
26
-
-
0028888832
-
Characterization of human Fas gene. Exon/intron organization and promoter region
-
Cheng J, Liu C, Koopman WJ, Mountz JD. Characterization of human Fas gene. Exon/intron organization and promoter region. J Immunol 1995;154:1239-45.
-
(1995)
J Immunol
, vol.154
, pp. 1239-1245
-
-
Cheng, J.1
Liu, C.2
Koopman, W.J.3
Mountz, J.D.4
-
27
-
-
0027434082
-
Complementation of a mutant cell line: Central role of the 91 kDa polypeptide of ISGF3 in the interferon-α and -γ signal transduction pathways
-
Muller M, Laxton C, Briscoe J, et al. Complementation of a mutant cell line: central role of the 91 kDa polypeptide of ISGF3 in the interferon-α and -γ signal transduction pathways. EMBO J 1993;12:4221-8.
-
(1993)
EMBO J
, vol.12
, pp. 4221-4228
-
-
Muller, M.1
Laxton, C.2
Briscoe, J.3
-
28
-
-
5544237608
-
Final results of a randomised trial comparing "Tomudex" (raltitrexed) with 5-fluorouracil plus leucovorin in advanced colorectal cancer
-
"Tomudex" Colorectal Cancer Study Group
-
Cunningham D, Zalcberg JR, Rath U, et al. Final results of a randomised trial comparing "Tomudex" (raltitrexed) with 5-fluorouracil plus leucovorin in advanced colorectal cancer. "Tomudex" Colorectal Cancer Study Group. Ann Oncol 1996;7:961-5.
-
(1996)
Ann Oncol
, vol.7
, pp. 961-965
-
-
Cunningham, D.1
Zalcberg, J.R.2
Rath, U.3
-
29
-
-
0344783805
-
Phase II trial of oxaliplatin as first-line chemotherapy in metastatic colorectal cancer patients
-
Digestive Group of French Federation of Cancer Centers
-
Becouarn Y, Ychou M, Ducreux M, et al. Phase II trial of oxaliplatin as first-line chemotherapy in metastatic colorectal cancer patients. Digestive Group of French Federation of Cancer Centers. J Clin Oncol 1998;16:2739-44.
-
(1998)
J Clin Oncol
, vol.16
, pp. 2739-2744
-
-
Becouarn, Y.1
Ychou, M.2
Ducreux, M.3
-
30
-
-
0030818926
-
Phase II trial of irinotecan in patients with metastatic colorectal carcinoma
-
Pilot HC, Wender DB, O'Connell MJ, et al. Phase II trial of irinotecan in patients with metastatic colorectal carcinoma. J Clin Oncol 1997;15:2910-9.
-
(1997)
J Clin Oncol
, vol.15
, pp. 2910-2919
-
-
Pilot, H.C.1
Wender, D.B.2
O'Connell, M.J.3
-
31
-
-
1342290189
-
FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: A randomized GERCOR study
-
Tournigand C, Andre T, Achille E, et al. FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study. J Clin Oncol 2004;22:229-37.
-
(2004)
J Clin Oncol
, vol.22
, pp. 229-237
-
-
Tournigand, C.1
Andre, T.2
Achille, E.3
-
32
-
-
0032802737
-
Acute toxicity of an anti-Fas antibody in mice
-
Kakinuma C, Takagaki K, Yatomi T, et al. Acute toxicity of an anti-Fas antibody in mice. Toxicol Pathol 1999;27:412-20.
-
(1999)
Toxicol Pathol
, vol.27
, pp. 412-420
-
-
Kakinuma, C.1
Takagaki, K.2
Yatomi, T.3
-
33
-
-
0034032332
-
A novel murine anti-human Fas mAb which mitigates lymphadenopathy without hepatotoxicity
-
Ichikawa K, Yoshida-Kato H, Ohtsuki M, et al. A novel murine anti-human Fas mAb which mitigates lymphadenopathy without hepatotoxicity. Int Immunol 2000;12:555-62.
-
(2000)
Int Immunol
, vol.12
, pp. 555-562
-
-
Ichikawa, K.1
Yoshida-Kato, H.2
Ohtsuki, M.3
-
34
-
-
0029003501
-
Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression
-
Owen-Schaub LB, Zhang W, Cusack JC, et al. Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression. Mol Cell Biol 1995;15:3032-40.
-
(1995)
Mol Cell Biol
, vol.15
, pp. 3032-3040
-
-
Owen-Schaub, L.B.1
Zhang, W.2
Cusack, J.C.3
-
35
-
-
0033748796
-
p53 dependence of Fas induction and acute apoptosis in response to 5-fluorouracil-leucovorin in human colon carcinoma cell lines
-
Petak I, Tillman DM, Houghton JA. p53 dependence of Fas induction and acute apoptosis in response to 5-fluorouracil-leucovorin in human colon carcinoma cell lines. Clin Cancer Res 2000;6:4432-41.
-
(2000)
Clin Cancer Res
, vol.6
, pp. 4432-4441
-
-
Petak, I.1
Tillman, D.M.2
Houghton, J.A.3
-
36
-
-
0031806708
-
Characterization of structural p53 mutants which show selective defects in apoptosis but not cell cycle arrest
-
Ryan KM, Vousden KH. Characterization of structural p53 mutants which show selective defects in apoptosis but not cell cycle arrest. Mol Cell Biol 1998;18:3692-8.
-
(1998)
Mol Cell Biol
, vol.18
, pp. 3692-3698
-
-
Ryan, K.M.1
Vousden, K.H.2
-
37
-
-
0035862950
-
727 phosphorylation, differentially affecting specific target gene expression
-
727 phosphorylation, differentially affecting specific target gene expression. EMBO J 2001;20:91-100.
-
(2001)
EMBO J
, vol.20
, pp. 91-100
-
-
Kovarik, P.1
Mangold, M.2
Ramsauer, K.3
-
38
-
-
0033598839
-
727 requires p38 mitogen-activated protein kinase whereas IFN-γ uses a different signaling pathway
-
727 requires p38 mitogen-activated protein kinase whereas IFN-γ uses a different signaling pathway. Proc Natl Acad Sci U S A 1999;96:13956-61.
-
(1999)
Proc Natl Acad Sci U S A
, vol.96
, pp. 13956-13961
-
-
Kovarik, P.1
Stoiber, D.2
Eyers, P.A.3
-
39
-
-
0034383398
-
p53-inducible wip1 phosphatase mediates a negative feedback regulation of p38 MAPK-p53 signaling in response to UV radiation
-
Takekawa M, Adachi M, Nakahata A, et al. p53-inducible wip1 phosphatase mediates a negative feedback regulation of p38 MAPK-p53 signaling in response to UV radiation. EMBO J 2000;19:6517-26.
-
(2000)
EMBO J
, vol.19
, pp. 6517-6526
-
-
Takekawa, M.1
Adachi, M.2
Nakahata, A.3
-
41
-
-
0032566691
-
Protein kinase C isotypes controlled by phosphoinositide 3-kinase through the protein kinase PDK1
-
Le Good JA, Ziegler WH, Parekh DB, Alessi DR, Cohen P, Parker PJ. Protein kinase C isotypes controlled by phosphoinositide 3-kinase through the protein kinase PDK1. Science 1998;281:2042-5.
-
(1998)
Science
, vol.281
, pp. 2042-2045
-
-
Le Good, J.A.1
Ziegler, W.H.2
Parekh, D.B.3
Alessi, D.R.4
Cohen, P.5
Parker, P.J.6
|